Supply report · October 2026 register copy
Cough, Cold & Flu in Nigeria: the registration data
Across the 4 cough, cold and flu molecules Ogbogwu tracks, our October 2026 copy of the NAFDAC Greenbook lists 37 active registrations held by 25 companies — plus 26 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 37
- Companies
- 25
- New in the last 12 months
- 2
- Renewals due within a year
- 4
Who holds the registrations
The ten companies with the most active cough, cold and flu registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Vixa Pharmaceutical— 5 active
- 2.J & J Company West Africa— 4 active
- 3.Phillips Pharmaceuticals (Nigeria)— 3 active
- 4.Avro Pharma— 2 active
- 5.Maxwell Lifecare— 2 active
- 6.SKG - Pharma— 2 active
- 7.A.C. Drugs— 1 active
- 8.Elbe Pharma Nigeria— 1 active
- 9.Emcure Nigeria— 1 active
- 10.Emzor Pharmaceutical Industries— 1 active
Where the products are made
Maker country as the register records it, across the 37 active registrations.
- India— 14 (38%)
- Nigeria— 12 (32%)
- China— 4 (11%)
- South Africa— 4 (11%)
- Indonesia— 1 (3%)
- Malaysia— 1 (3%)
- Spain— 1 (3%)
Dosage forms
- Syrup— 27 active
- Capsule— 4 active
- Caplet— 2 active
- Tablet— 2 active
- Solution/Drops— 1 active
- Suspension— 1 active
Newest registrations
The latest cough, cold and flu approvals in our copy — 2 products were registered in the twelve months to October 2026.
4 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order.
The molecules behind these numbers
- Dextromethorphan — 5 active registrations
- Guaifenesin — 4 active registrations
- Bromhexine — 1 active registrations
- Ambroxol — 0 active registrations
“Cough, Cold & Flu” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
Manufacturing or exporting cough, cold and flu medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.